85 FR 250 pgs. 86556-86557 - Atrazine, Simazine, and Propazine Registration Review; Draft Endangered Species Act Biological Evaluations; Extension of Comment Period
Type: NOTICEVolume: 85Number: 250Pages: 86556 - 86557
Pages: 86556, 86557Docket number: [EPA–HQ–OPP–2020–0514; FRL–10018–29]
FR document: [FR Doc. 2020–28828 Filed 12–29–20; 8:45 am]
Agency: Environmental Protection Agency
Official PDF Version: PDF Version
[top]
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPP-2020-0514; FRL-10018-29]
Atrazine, Simazine, and Propazine Registration Review; Draft Endangered Species Act Biological Evaluations; Extension of Comment Period
AGENCY:
Environmental Protection Agency (EPA).
ACTION:
Notice; extension of comment period.
SUMMARY:
EPA issued a notice in the Federal Register of November 6, 2020, opening a 60-day comment period on the draft nationwide biological evaluations for the registration review of the pesticides atrazine, simazine, and propazine relative to the potential effects on threatened and endangered species and their designated critical habitats. This document extends the comment period for 45 days, from January 5, 2021 to February 19, 2021.
DATES:
Comments, identified by docket identification (ID) number EPA-HQ-OPP-2020-0514 must be received on or before February 19, 2021.
ADDRESSES:
Follow the detailed instructions provided under ADDRESSES in the Federal Register document of November 6, 2020 (85 FR 71071) (FRL-10015-77).
FOR FURTHER INFORMATION CONTACT:
Tracy Perry, Pesticide Re-Evaluation Division (7508P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number: (703) 308-0128; email address: perry.tracy@epa.gov.
SUPPLEMENTARY INFORMATION:
[top] This document extends the public comment period established in the Federal Register document of November 6, 2020 (85 FR 71071) (FRL-10015-77), which opened a 60-day public comment period for the draft nationwide biological evaluations for the registration review of the pesticides atrazine, simazine, and propazine relative to the potential effects on threatened and endangered species and their designated critical habitats. As noted in that document, the schedule for conducting the atrazine and simazine biological evaluations was negotiated as part of a partial settlement agreement pursuant to a joint
After considering a number of requests to extend the comment period received from various stakeholders, EPA is extending the comment period for the following reasons: (1) The length, complexity, and highly technical nature of the draft biological evaluations; (2) the need for some stakeholders to engage experts familiar with the subject matter to assist them with providing comments; (3) the large number of stakeholders potentially impacted by the draft biological evaluations; (4) the importance of soliciting feedback from stakeholders who may be affected; and (5) the stakeholders' need for additional time to review and develop constructive comments for these complex and lengthy documents.
To submit comments, or access the docket, please follow the detailed instructions provided under ADDRESSES in the Federal Register document of November 6, 2020. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT .
Authority:
7 U.S.C. 136 et seq.
Dated: December 8, 2020.
Alexandra Dapolito Dunn,
Assistant Administrator, Office of Chemical Safety and Pollution Prevention.
[FR Doc. 2020-28828 Filed 12-29-20; 8:45 am]
BILLING CODE 6560-50-P